PE anti-human CD19 [HIB19] and 2 more items

The University of Virginia awarded contract A207_PO-0453108 to BioLegend Inc. on June 26, 2026, for the provision of laboratory reagents and diagnostic materials. The contract, valued at $324, encompasses the delivery of three distinct line items to recipient Jing Gao. The awarded items include PE (phycoerythrin) anti-human CD19 [HIB19] monoclonal antibody at a unit price of $46.20, APC (allophycocyanin) anti-human CD8 [SK1] monoclonal antibody at a unit price of $227.50, and Stop Solution for TMB (tetramethylbenzidine) Substrate at a unit price of $25.20 per unit, with two units of the stop solution ordered.

These reagents are consistent with flow cytometry and immunoassay applications commonly utilized in biomedical research settings. The fluorescently-conjugated monoclonal antibodies targeting CD19 and CD8 surface antigens are used for cellular identification and analysis, while the TMB stop solution supports colorimetric enzyme-linked immunosorbent assay (ELISA) procedures. As a state and local contract award issued by a Virginia public institution, the performance location is the University of Virginia in Virginia.